Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
73,315.04
(
0.46%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

asmarterwookie

Send PM Follow Ignore
Followers 65
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

asmarterwookie

Re: Protector post# 309308

Monday, 08/21/2017 10:59:47 AM

Monday, August 21, 2017 10:59:47 AM

Post# of 347009

I think that I will go with Memorial Sloan Kettering as far as Bavituximab is concerned.



Me too.

Will a bonafide trial result?

As far as the NCCN trials...they are recruiting yet no recruits yet.

wook

Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote